SRx Health Solutions Announces First Quarter 2025 Financial Results

Core Insights - SRx Health Solutions Inc. reported a significant improvement in its financial performance for Q1 2025, with EPS improving by 90% year-over-year to $(0.37) and adjusted EBITDA loss improving by 54% to $(0.6) million [1][9] - The company generated net sales of $7.2 million, a decrease of 9% year-over-year, primarily due to the closure of Halo's direct-to-consumer channel [4][9] - The merger with SRx Health Solutions was completed on April 24, 2025, leading to a name change from Better Choice Company Inc. to SRx Health Solutions Inc. [2] Financial Performance - Adjusted EBITDA margin improved by 865 basis points year-over-year to (9)% [1][9] - Net loss improved by 66% year-over-year to $(1.0) million [9] - Gross margin remained consistent at 33% [9] Operational Highlights - The company executed a digital-first strategy and shifted marketing investments to enhance brand awareness [2] - Inventory levels improved by approximately 50% over the last 15 months, with fill rates averaging 98% for the quarter [2] - The financial results reported only reflect US operations prior to the merger and do not include Canadian operations [2] Liquidity and Capital Resources - As of March 31, 2025, cash and cash equivalents totaled $1.1 million [5]